1. Home
  2. HRTX vs ABEO Comparison

HRTX vs ABEO Comparison

Compare HRTX & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRTX
  • ABEO
  • Stock Information
  • Founded
  • HRTX 1983
  • ABEO 1974
  • Country
  • HRTX United States
  • ABEO United States
  • Employees
  • HRTX N/A
  • ABEO N/A
  • Industry
  • HRTX Biotechnology: Pharmaceutical Preparations
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • HRTX Health Care
  • ABEO Health Care
  • Exchange
  • HRTX Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • HRTX 276.1M
  • ABEO 332.0M
  • IPO Year
  • HRTX 1987
  • ABEO 1980
  • Fundamental
  • Price
  • HRTX $1.35
  • ABEO $6.83
  • Analyst Decision
  • HRTX Strong Buy
  • ABEO Strong Buy
  • Analyst Count
  • HRTX 2
  • ABEO 6
  • Target Price
  • HRTX $4.50
  • ABEO $18.17
  • AVG Volume (30 Days)
  • HRTX 2.6M
  • ABEO 702.3K
  • Earning Date
  • HRTX 08-08-2025
  • ABEO 08-14-2025
  • Dividend Yield
  • HRTX N/A
  • ABEO N/A
  • EPS Growth
  • HRTX N/A
  • ABEO N/A
  • EPS
  • HRTX N/A
  • ABEO 0.99
  • Revenue
  • HRTX $149,694,000.00
  • ABEO $400,000.00
  • Revenue This Year
  • HRTX $10.62
  • ABEO N/A
  • Revenue Next Year
  • HRTX $12.99
  • ABEO $339.63
  • P/E Ratio
  • HRTX N/A
  • ABEO $6.91
  • Revenue Growth
  • HRTX 9.78
  • ABEO N/A
  • 52 Week Low
  • HRTX $1.04
  • ABEO $3.93
  • 52 Week High
  • HRTX $2.68
  • ABEO $7.54
  • Technical
  • Relative Strength Index (RSI)
  • HRTX 36.48
  • ABEO 52.71
  • Support Level
  • HRTX $1.33
  • ABEO $6.70
  • Resistance Level
  • HRTX $1.43
  • ABEO $7.15
  • Average True Range (ATR)
  • HRTX 0.07
  • ABEO 0.31
  • MACD
  • HRTX 0.02
  • ABEO -0.02
  • Stochastic Oscillator
  • HRTX 45.45
  • ABEO 46.62

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: